Is LENSAR Inc (LNSR) overvalued? · rev $29.9M
LENSAR Inc (LNSR) is a medical devices company listed on US.
This page asks whether LENSAR Inc (LNSR) looks expensive on cached numbers — not a short thesis.
Latest reported LNSR revenue for 2026-06-30 was $29.9M. Net income was $39.9M. LNSR currently screens at market cap $156.7M.
LNSR currently screens at market cap $156.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next LNSR 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the LNSR stock page for the full model, not this heading.
Not investment advice.